Skip to content
Clinical Trials – home

Gastrointestinal disorder Treatment

2 / 2 trials open to patients3 countries

In short

Gastrointestinal disorders affect millions of people worldwide, causing symptoms that range from occasional discomfort to serious, life-altering complications. Understanding how these conditions are treated—both with established medical approaches and through promising new therapies being tested in clinical trials—can help patients and their families make informed decisions about managing digestive health.

Key points

  • Gastrointestinal disorders affect millions globally, but many can be effectively managed with the right combination of treatments tailored to individual needs.
  • Treatment approaches range from simple lifestyle changes and dietary modifications for mild functional disorders to complex medication regimens and procedures for structural conditions.
  • The gut-brain connection is real and powerful—stress and emotions significantly impact digestive symptoms, which is why psychological therapies like cognitive behavioral therapy work as well as medication for some conditions.
  • Clinical trials are actively exploring innovative treatments including next-generation biologics, gene therapy, and microbiome-based therapies that may offer new hope for patients who don't respond to current treatments.
  • Building a strong support network of healthcare providers, family, and friends is crucial for managing the physical and emotional challenges of living with a chronic digestive disorder.
  • Mental health care is not optional—patients with gastrointestinal disorders have higher rates of anxiety and depression, and addressing these issues improves both psychological well-being and digestive symptoms.
  • Keeping a food diary helps identify personal trigger foods, allowing patients to avoid problematic items while maintaining adequate nutrition for overall health.
  • Open, honest communication with your healthcare team about all symptoms, even embarrassing ones, is essential for receiving the most effective treatment and improving quality of life.

Understanding Treatment Goals for Digestive Health Problems

When someone is diagnosed with a gastrointestinal disorder—a condition affecting any part of the digestive system from the mouth to the rectum—the main goals of treatment are to control symptoms, improve quality of life, and when possible, slow or stop disease progression. The gastrointestinal tract, also called the GI tract, is a complex system that includes the esophagus, stomach, small intestine, large intestine, and supporting organs like the liver, pancreas, and gallbladder.

Treatment approaches vary significantly depending on the type of disorder, its severity, and how it affects each individual patient. Some gastrointestinal diseases are acute, meaning they appear suddenly and last only a short time, while others are chronic, affecting people for months or years. Additionally, these conditions fall into two main categories: functional disorders, where the digestive tract looks normal but doesn't work properly, and structural disorders, where visible physical problems can be detected during examination.

Medical societies and healthcare organizations have established standard treatments based on years of research and clinical experience. At the same time, scientists continue to explore new therapies through clinical trials, testing innovative drugs and approaches that may offer better outcomes for patients who don't respond well to existing treatments. The relationship between a patient and their healthcare team is crucial in determining which treatment path will work best.

Standard Treatment Approaches for Gastrointestinal Disorders

The foundation of treating gastrointestinal disorders typically begins with lifestyle modifications and dietary changes. For many functional gastrointestinal disorders—conditions where the digestive system behaves abnormally despite appearing normal—simple adjustments can make a significant difference. These include eating a diet rich in fiber, increasing physical activity, managing stress levels, and avoiding foods that trigger symptoms.

Dietary management plays a particularly important role in treatment. For conditions like irritable bowel syndrome (IBS), healthcare providers often recommend a low-FODMAP diet, which reduces intake of certain carbohydrates that the small intestine doesn't absorb well. These fermentable oligosaccharides, disaccharides, monosaccharides, and polyols are found in foods like wheat, garlic, onions, and certain fruits. Patients with celiac disease must completely avoid gluten, a protein found in wheat, barley, and rye.

Medication remains a cornerstone of treatment for both functional and structural gastrointestinal disorders. Several categories of drugs are commonly prescribed. Antispasmodics help reduce muscle contractions in the intestines, relieving cramping and pain associated with conditions like IBS. Neuromodulators, including certain antidepressants, work by affecting how the brain and gut communicate, reducing pain sensitivity and improving bowel function even in patients without depression.

For inflammatory conditions, treatment becomes more intensive. Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, often requires medications that suppress the immune system or reduce inflammation throughout the body. These may include corticosteroids for short-term symptom control, immunomodulators that alter immune system activity, and biologic therapies that target specific proteins involved in inflammation.

Proton pump inhibitors and H2 blockers are standard treatments for gastroesophageal reflux disease (GERD), reducing the amount of acid the stomach produces and allowing damaged esophageal tissue to heal. For bacterial infections like those caused by H. pylori, which can lead to stomach ulcers, doctors prescribe combinations of antibiotics along with acid-reducing medications.

The duration of therapy varies widely. Some patients with functional disorders may need medication only during symptom flares, while others with chronic inflammatory conditions may require long-term or even lifelong treatment to maintain remission. Regular monitoring through follow-up appointments, blood tests, and sometimes endoscopic procedures helps doctors assess whether treatments are working and adjust them as needed.

Side effects are an important consideration with any medication. Antispasmodics can cause dry mouth, blurred vision, or difficulty urinating. Antidepressants used as neuromodulators may cause drowsiness, weight changes, or sexual dysfunction, although these effects often occur at lower doses than when used for depression. Immune-suppressing medications for inflammatory bowel disease can increase infection risk and may require regular blood monitoring to check for liver problems or reduced blood cell counts.

Minimally Invasive Procedures

Many gastrointestinal disorders can be treated through procedures that don't require major surgery. Endoscopy, where a thin, flexible tube with a camera is inserted through the mouth or rectum, allows doctors to both diagnose and treat problems. During an upper endoscopy, physicians can remove polyps, stop bleeding, or dilate narrowed areas of the esophagus. Colonoscopy enables removal of precancerous polyps from the colon, potentially preventing cancer development.

Endoscopic retrograde cholangiopancreatography (ERCP) combines endoscopy with X-rays to treat blockages in the bile ducts and pancreatic duct, including those caused by gallstones. This procedure can relieve jaundice and prevent serious complications without the need for open surgery.

Psychological Interventions

Cognitive behavioral therapy (CBT) has emerged as an effective treatment for functional gastrointestinal disorders, particularly IBS. This form of psychotherapy helps patients understand how their thoughts, emotions, and behaviors affect their physical symptoms. Research consistently shows that CBT can reduce symptoms as effectively as medication for some patients.

The connection between stress and digestive symptoms is well-established. Anxiety and worry can disrupt the delicate balance of digestion, either slowing it down and causing constipation or speeding it up and causing diarrhea. CBT teaches patients skills to manage stress, change unhelpful thought patterns, and modify behaviors that may worsen symptoms. Treatment typically consists of four to seven sessions, with most patients experiencing significant improvement by the end of therapy.

Another psychological approach, gut-directed hypnotherapy, helps patients achieve deep relaxation while focusing on improving gut function. This technique has shown particular promise for IBS patients who haven't responded well to other treatments.

Treatment in Clinical Trials: Exploring New Frontiers

While standard treatments help many patients manage their gastrointestinal disorders, researchers continue to search for more effective therapies through clinical trials. These carefully designed studies test new drugs, procedures, and treatment approaches to determine if they're safe and whether they work better than existing options.

Understanding Clinical Trial Phases

Clinical trials progress through distinct phases, each designed to answer specific questions. Phase I trials focus primarily on safety, testing a new treatment in a small group of healthy volunteers or patients to determine safe dosage ranges and identify potential side effects. Phase II trials enroll more participants and evaluate whether the treatment actually works—does it improve symptoms, reduce inflammation, or achieve other intended goals? Phase III trials involve large groups of patients and compare the new treatment directly against standard therapy to see if it offers meaningful advantages.

After a treatment is approved for use, Phase IV studies continue monitoring its long-term effects and safety in the general population, sometimes revealing rare side effects that weren't detected in earlier trials.

Innovative Molecules and Therapies in Development

For inflammatory bowel disease, researchers are testing next-generation biologic therapies that target inflammatory pathways with greater precision than existing drugs. Some experimental treatments block specific molecules called cytokines that drive inflammation in the intestinal wall. Others aim to restore balance to the gut's immune system rather than simply suppressing it, potentially offering symptom control with fewer side effects.

Gene therapy approaches are being explored for certain rare digestive disorders. These experimental treatments aim to correct genetic defects that cause disease by introducing healthy copies of genes into a patient's cells. While still in early stages of testing, gene therapy holds promise for conditions that currently have limited treatment options.

Enzyme replacement therapies are under investigation for conditions where the digestive system doesn't produce enough of certain enzymes needed to break down food. Researchers are developing new formulations that can survive the acidic environment of the stomach and deliver enzymes where they're needed in the small intestine.

For functional disorders like IBS, scientists are testing novel drugs that work on the gut-brain axis—the complex communication network between the digestive system and the central nervous system. Some experimental medications target specific receptors in the intestine that control motility and sensation, potentially offering symptom relief without affecting the brain directly.

Microbiome-Based Therapies

The trillions of bacteria living in the digestive tract, collectively called the gut microbiome, play crucial roles in digestion, immune function, and overall health. Clinical trials are exploring whether altering the composition of this bacterial community can treat gastrointestinal disorders.

Some studies are testing specially designed probiotic formulations—beneficial bacteria that may improve gut health. Unlike over-the-counter probiotics, these experimental products contain specific bacterial strains selected for their ability to reduce inflammation, strengthen the intestinal barrier, or produce compounds that promote healing.

Fecal microbiota transplantation, where healthy gut bacteria from a donor are transferred to a patient's digestive system, has shown success in treating certain infections and is now being studied for inflammatory bowel disease and other conditions. Clinical trials are working to identify which patients are most likely to benefit and to develop standardized, safe preparations for this therapy.

Participation and Eligibility

Clinical trials for gastrointestinal disorders are conducted at medical centers around the world, including locations in the United States, Europe, and other regions. Each study has specific eligibility criteria based on factors like the type and severity of disease, previous treatments tried, age, and overall health status. Patients interested in participating typically need a referral from their doctor and must undergo screening to determine if they meet the study requirements.

Participation in clinical trials offers potential benefits, including access to cutting-edge treatments before they become widely available and close monitoring by expert medical teams. However, there are also considerations: experimental treatments may not work or could cause unexpected side effects, and trials often require frequent visits and testing. Patients considering enrollment should discuss the potential risks and benefits thoroughly with their healthcare team.

Most common treatment methods

  • Lifestyle and Dietary Modifications
    • Eating a diet high in fiber and low in processed foods to improve bowel function
    • Avoiding trigger foods such as those high in caffeine, fat, or sugar
    • Following a low-FODMAP diet for irritable bowel syndrome
    • Eliminating gluten for celiac disease management
    • Increasing physical activity and exercise to reduce bloating and improve motility
    • Managing stress through relaxation techniques and behavioral changes
    • Maintaining adequate hydration by drinking plenty of water
  • Medication Therapy
    • Over-the-counter laxatives for constipation relief
    • Antispasmodics to reduce intestinal muscle contractions and cramping
    • Proton pump inhibitors and H2 blockers for acid reduction in GERD
    • Antidepressants and neuromodulators to affect gut-brain communication
    • Antibiotics for bacterial infections and diverticulitis
    • Immunomodulators and biologic therapies for inflammatory bowel disease
    • Corticosteroids for short-term control of inflammation
  • Minimally Invasive Procedures
    • Upper endoscopy for examining and treating esophagus, stomach, and duodenum disorders
    • Colonoscopy for colon examination and polyp removal
    • Endoscopic retrograde cholangiopancreatography (ERCP) for bile and pancreatic duct blockages
    • Sigmoidoscopy for examining the rectum and lower colon
    • Endoscopic ultrasound for detecting gallstones and assessing digestive organs
  • Psychological and Behavioral Interventions
    • Cognitive behavioral therapy (CBT) to address thought patterns and behaviors affecting symptoms
    • Gut-directed hypnotherapy for deep relaxation and improved gut function
    • Stress management techniques including diaphragmatic breathing and progressive muscle relaxation
    • Behavioral therapy to develop coping skills and make positive health changes
  • Surgical Treatments
    • Hemorrhoid removal for large, painful, or persistent hemorrhoids
    • Surgery for diverticulitis complications such as bleeding or bowel obstruction
    • Surgical procedures for structural abnormalities and blockages

Living Well with a Gastrointestinal Disorder

Managing a chronic gastrointestinal disorder extends beyond medical treatment. The personal nature of digestive symptoms—including bloating, gas, diarrhea, and urgent bowel movements—can lead to feelings of embarrassment, isolation, and anxiety about being in public places without easy bathroom access.

Developing practical strategies can significantly improve daily life. Many patients benefit from keeping a food diary to identify which foods trigger their symptoms, allowing them to avoid problematic items while ensuring adequate nutrition. Planning ahead by locating bathrooms before visiting unfamiliar places can reduce anxiety. Some organizations even offer cards that explain the urgent need for restroom access, which can be helpful when traveling or in public spaces.

Building a support network of family, friends, and healthcare providers who understand the challenges of living with a digestive disorder makes coping easier. Support groups, whether in-person or online, connect patients with others facing similar struggles, reducing the sense of isolation that often accompanies these conditions.

Self-care practices deserve priority. This includes dedicating time to prepare symptom-friendly meals, engaging in appropriate forms of exercise that help rather than aggravate the condition, and practicing relaxation techniques such as deep breathing or meditation. Some patients find that aromatherapy using essential oils like peppermint, ginger, or lavender helps manage symptoms like nausea and discomfort.

Regular communication with healthcare providers ensures that treatment plans remain effective as the disease or a patient's circumstances change. Being honest about symptoms, even embarrassing ones, allows doctors to make informed decisions about adjusting medications or trying new approaches. Patients should feel empowered to ask questions, request clarification about their diagnosis and treatment, and discuss any concerns about side effects or quality of life.

For many people with gastrointestinal disorders, smoking cessation becomes crucial. Smoking weakens the muscle that prevents stomach acid from backing up into the esophagus, worsening GERD symptoms. It also significantly aggravates Crohn's disease and interferes with how the liver processes medications. Quitting smoking often leads to noticeable improvement in digestive symptoms.

Sleep quality affects gastrointestinal health in ways that researchers are still working to fully understand. Poor sleep can trigger or worsen digestive problems, while gastrointestinal symptoms can interfere with getting adequate rest. Establishing good sleep habits—maintaining a regular sleep schedule, creating a comfortable sleep environment, and avoiding large meals close to bedtime—benefits both sleep quality and digestive health.

Did you know?

  1. Gastrointestinal disorders affect 60-70 million people in America alone, making digestive problems far more common than many realize, yet they often remain undiagnosed or undertreated.
  2. Diagnostic test results influence approximately 70% of all healthcare decisions, but only 3-5% of healthcare budgets are allocated to diagnostic services for conditions including gastrointestinal disorders.
  3. The gut contains more nerve cells than the spinal cord, and this extensive nervous system communicates constantly with the brain, which is why stress and emotions can have such powerful effects on digestive symptoms.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Gastrointestinal disorder

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:NorthSea Therapeutics B.V.

Autism spectrum disorder+1

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Allogeneic Faecal Microbiota, Pooled
  • Sponsor:Assistance Publique Hopitaux De Paris
See all 2 trials →filters applied: condition = Gastrointestinal disorder

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).